Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Properties of Transition Metals02:58

Properties of Transition Metals

30.0K
Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
30.0K
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

321
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
321
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

363
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
363
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.2K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.2K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.2K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.2K
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.2K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.

mAbs·2026
Same author

PBPK Modelling of PROTACs: Learnings from ARV-110 as a Case Example.

The AAPS journal·2026
Same author

TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data.

Clinical pharmacology and therapeutics·2026
Same author

A hybrid PKPD agent-based model of the tumour immune interaction: effects of anti-cancer combination therapy.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.

CPT: pharmacometrics & systems pharmacology·2025
Same author

An Asymptotic Analysis of Bivalent Monoclonal Antibody-Antigen Binding.

Bulletin of mathematical biology·2025

Related Experiment Video

Updated: Feb 9, 2026

Oscillation and Reaction Board Techniques for Estimating Inertial Properties of a Below-knee Prosthesis
08:08

Oscillation and Reaction Board Techniques for Estimating Inertial Properties of a Below-knee Prosthesis

Published on: May 8, 2014

17.3K

Mathematical properties and parameter estimation for transit compartment pharmacodynamic models.

James W T Yates1

  • 1Discovery DMPK, AstraZeneca R&D, Alderley Park, Cheshire, UK. james.yates@astrazeneca.com

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|April 15, 2008
PubMed
Summary

Mathematical analysis of pharmacodynamic models reveals that linear transit compartments, a common substructure, exhibit increased sensitivity and attenuated drug effects with longer cascades. This enhances understanding of model behavior and experimental design.

More Related Videos

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
13:42

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria

Published on: September 7, 2012

22.1K
Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 3, 2007

9.2K

Related Experiment Videos

Last Updated: Feb 9, 2026

Oscillation and Reaction Board Techniques for Estimating Inertial Properties of a Below-knee Prosthesis
08:08

Oscillation and Reaction Board Techniques for Estimating Inertial Properties of a Below-knee Prosthesis

Published on: May 8, 2014

17.3K
Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
13:42

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria

Published on: September 7, 2012

22.1K
Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 3, 2007

9.2K

Area of Science:

  • Pharmacodynamics
  • Mathematical Biology
  • Systems Pharmacology

Background:

  • Recent pharmacodynamic modeling trends emphasize mechanistic structures.
  • Common model substructures like feedback loops and time-delays require mathematical analysis.
  • Linear transit compartments are a prevalent pharmacodynamic model substructure.

Purpose of the Study:

  • To mathematically analyze the properties of linear transit compartments in pharmacodynamic models.
  • To characterize the range of behaviors reproducible by these models.
  • To inform experimental design through prior mathematical analysis.

Main Methods:

  • Analysis of linear transit compartment substructures within pharmacodynamic models.
  • Investigation of model behavior as the length of the cascade chain increases.
  • Examination of the limiting case approaching a pure time-delay.

Main Results:

  • Increased cascade length in linear transit compartments leads to a pure time-delay in the limiting case.
  • Model behavior becomes increasingly sensitive to parameter perturbations.
  • Drug effect is attenuated, but the duration of action is prolonged.

Conclusions:

  • Mathematical analysis of linear transit compartments reveals key properties influencing model behavior.
  • Understanding these properties enhances the utility of pharmacodynamic models in research.
  • Prior mathematical analysis can optimize experimental design and interpretation.